First human tests begin for new drug candidate
NCT ID NCT07141199
Summary
This is an early-stage study to check the safety and see how the body processes a new drug called ABBV-8736. It involves 24 healthy adult volunteers who will receive the drug or a placebo through an IV. The main goal is to understand the drug's side effects and how it moves through and out of the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 277377
Grayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.